Take 5 minutes to catch up on Infection Control Today’s highlights for the week ending February 4.
Here are 5 highlights from ICT®’s wide-ranging coverage of the infection prevention and control world. Everything from interviews with known opinion leaders, to the news that infection preventionists and other health care professionals can use on their jobs.
Getting a Head Start on Treating Long COVID
Jamie Seltzer, the director of scientific and medical outreach for #MEAction: “We have so much history—recent history as well as 100 years ago—to tell us that it would be incredibly unusual and atypical if SARS-CoV-2 were the only viral infection that did not lead to post-viral complications.”
“Stealth Omicron” Starting to Get Noticed, Setting Off Some Alarms
Initial data suggest that it appears to be more infectious than even the highly infectious original Omicron variant.
Long COVID Will Linger Even After the Pandemic Leaves
Many people suffer from long COVID, and since COVID-19 is a fairly recent development experts aren’t sure what “long” means exactly. Weeks? Months? Years? A lifetime?
Not Enough PPE? Print Some Out
A public/private enterprise taps into the entrepreneurial urge that will hopefully help the United States avoid the disastrous shortages of personal protective equipment that deviled the health care system in the first months of the COVID-19 pandemic.
When COVID Turns 2: Infection Preventionists Take Stock
As we approach year 3, the contribution made by infection preventionists in battling this pandemic needs to be appreciated more.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.